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Abstract   
There is a complex interaction between genetic, metabolic, and environmental factors in 
determining the risk of Metabolic Syndrome (MetS). The aim of this study was to investigate the 
interaction between the dietary intake of iron, copper, zinc, manganese, selenium and iodine 
(assessed by 24 recall) with vascular endothelial growth factor variants (rs6921438, rs4416670, 
rs6993770, and rs10738760), on the risk of metabolic syndrome. Two hundred and forty eight 
individuals with MetS and 100 individuals without MetS recruited. Dietary intake and the daily 
average of energy and nutrients intake were obtained by questionnaire and quantified using Diet 
Plan 6 software. DNA was extracted from EDTA anticoagulated whole blood. The SNPs were 
assessed using using a Sequenom iPLEX Gold assay. Data analysis was undertaken using the 
Student’s t-test, χ2 test and logistic regression using SPSS 11.5 software. There was a significant 
interaction between low dietary iron intake with rs6993770 (β= 0.10, p<0.05), and a low dietary 
zinc and a high manganese intake with rs6921438 in relation to the presence of metabolic 
syndrome (β= -0.17, p<0.05, β= -0.30, p<0.05, respectively). Our data showed the association of 
rs6993770 with iron intake and rs6921438 with zinc and manganese intake, indicating further 
investigating in a larger population to evaluate their values.  
Key words: Metabolic syndrome, VEGF, polymorphism, SNPs, trace element  
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 Introduction   
Metabolic syndrome (MetS) is defined by a clustering of four major cardiovascular risk factors: 
Obesity, insulin resistance (hyperglycemia), dyslipidemia (low serum HDL cholesterol, and high 
serum fasted triglycerides), and arterial hypertension (Azimi-Nezhad et al. 2012). The prevalence 
of MetSis increasing in the urbanized world and in developing nations (Li et al. 2013). Although 
the exact mechanism leading to MetS is still unclear although there is likely to be a complex 
interaction between genetic, metabolic, and environmental factors (Li et al. 2013). Excess weight 
increases the risk of multiple conditions that can contribute to the aetiology of MetS. 
The polypeptide VEGF is a potent regulator of angiogenesis (Shahbazi 2002). It is generally 
accepted that the vascular endothelial growth factor/vascular endothelial growth factor receptor 
(VEGF/ VEGFR) system accounts for much of the angiogenic activities in adipose tissue (Lijnen 
2008). Angiogenesis involves the construction of new capillaries from main blood vessels, and it 
is a pivotal mechanism for transporting essential nutrients into the cells. The VEGF gene 
contains several polymorphic regions known to influence VEGF expression (Choi et al. 2011). 
Angiogenesis and vasculogenesis are dependent on several growth factors and their associated 
tyrosine kinases. VEGF acts both as an activator and as a survival factor for endothelial cells of 
newly formed blood vessels (Wada et al. 2010). Neovascularization refers to the formation of 
new blood vessels. This important biological process is known to be sensitive to copper levels as 
lowering copper levels appears to be a potentially effective antiangiogenic approach to cancer 
treatment (Brewer et al. 2005), and  copper egress is induced by VEGF, and this dynamic 
developmental process is required for endothelial tube formation (Qin et al. 2006).  
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A genome-wide association study (GWAS), identified four single-nucleotide polymorphisMetS 
(SNPs), (rs6921438, rs4416670, rs6993770, and rs10738760), that explained up to 50% of the 
heritability of serum VEGFA (Stathopoulou et al. 2013).  
Trace elements such as iron (Fe), zinc (Zn), copper (Cu), manganese (Mn), iodine (I) and 
selenium (Se) are essential for optimum metabolic function. These elements serve a variety of 
functions including catalytic, structural and regulatory activities in which they interact with 
macromolecules such as enzymes, pro-hormones, presecretory granules and biological 
membranes (Aggett 1985). Some trace elements, for example zinc, iron, selenium and copper 
play important roles in cellular and molecular processes in biology.  
Cardiovascular disease is the leading cause of death, which is an important consequence of MetS, 
and an imbalance of trace elements and metals appears to be a possible cause of coronary heart 
disease (CHD) (Easter Renee et al. 2010, Mutakin et al. 2013). Silva et al (2013) showed that the 
trace elements  iron, copper and vascular endothelial growth factor are related and indicating 
higher plasma levels of these elements may be associated with the angiogenic process in breast 
cancer. To overcome the significant gap between molecular biology, physiology and more 
traditional nutrition research, nutrigenomics has been initiated as a new innovative strategy 
which focusing on gene-environment interactions and the relevance of genotype changes e.g. 
single nucleotide polymorphisMetS (SNPs) for individual variation in responses to food, dietary 
pattern and susceptibility to develop nutrition-related diseases (Afman et al. 2012). The 
investigation of the inetractions of these new genetic variants with dietary trace element in the 
pathogenesis of MetS might give some insight into the relationship between gene variants 
affecting the expression of VEGF regulating and dietary trace elements. We therefore 
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investigated whether the interaction between rs6921438, rs4416670, rs6993770, and rs10738760 
SNPs and dietary trace element are associated with the risk of MetS. 
  
Method and material:  
Subjects:  
A total of 350 men and women were recruited from three areas in Mashhad, North East of Iran, 
using a stratified cluster random method. The diagnosis of MetS was based on the modified 
International Diabetes Federation (IDF) criteria (Hadaegh et al. 2009). The criteria comprised: 
abdominal obesity (waist circumference ≥94 cm for men and ≥80 cm for women),  and any two 
of the following factors: triglycerides >1.7 mmol/L (>150 mg/dl), or treatment for dyslipidemia; 
high-density lipoprotein-cholesterol (HDL-C) <1.03 mmol/L (<40 mg/dl) in men and <1.29 
mmol/L (<50 mg/dl) in women; blood pressure ≥130/85 mmHg or antihypertensive treatment; 
fasting blood glucose ≥5.6 mmol/L (>100 mg/dl) or treatment for diabetes. Patients who were on 
oral contraceptives, or hormone replacement therapy, antioxidant and mineral supplements and 
herbal remedies as well as pregnant women and patients with chronic disease were excluded 
from the study. None of the subjects had overt clinical features of infection, or chronic 
inflammatory disease and all of subjects were negative for HBS antigen, anti-HCV antibody, and 
anti-HIV antibody. From 350 subjects, 248 patients were diagnosed with METS through physical 
exam and laboratory measurements, and 100 control s were recruited.  Two subjects were 
excluded for the complete questioners. The study protocol was approved by the Ethics 
Committee of Mashhad University of Medical Sciences (Mashhad, Iran). Written informed 
consent was obtained from all subjects prior to their participation in the study.  
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Anthropometric measurements and data collection 
The demographic, anthropometric and lifestyle data were collected by two trained health care 
professionals. The height , weight and waist circumference (WC) were measured using standard 
methods (Azimi-Nezhad  et al. 2012). WC was determined by measuring waist diameter in the 
level of midpoint between iliac crests and lower border of tenth rib (Azimi-Nezhad et al. 2012). 
The average of three measurements was considered as WC. Body mass index (BMI) was 
calculated by weight in kilogram divided to square of height in meter (kg/m2).  
 Biochemical analysis  
A full fasted lipid profile, comprising of total cholesterol, triglycerides, high-density lipoprotein 
cholesterol (HDLC), low-density lipoprotein cholesterol (LDL-C), serum high sensitive C-
reactive protein (hs-CRP) and 12 hour fasting blood glucose were determined for each patient. 
Serum lipid and fasting blood glucose concentrations were measured by enzymatic methods.   
 Dietary assessment   
Dietary intake was assessed using 24 hour recall. Research dieticians provided instructions to the 
subjects with a booklet with letters representing small, medium, or large portions. The 
participants were asked to record a detailed description of all foods, beverages in 24 hour recall 
questionnaire. All records were checked by a dietician on completion and any incomplete 
information was clarified. The daily average of energy and nutrients intake was calculated by 
using the Diet plan6 software with Iranian food nutrients.  
Genotyping:  
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 DNA was extracted from all participants, and relative bio banks have been constructed in the 
BRC IGE-PCV. The SNPs rs6921438, rs4416670, rs6993770, and rs10738760 were genotyped 
using Geno screen© (http://genoscreen.fr) using a Sequenom® iPLEX Gold assay (Medium 
Throughput Genotyping Technology) (Services 2013) and in Kbioscience 
(http://www.kbioscience.co.uk) using the competitive allele-specific PCR (KASP) chemistry 
coupled with a FRET-based genotyping system (http://www.kbioscience.co.uk/reagents/ 
KASP/KASP.html)  
Statistical analysis:  
The Hardy Weinberg equation was used to determine whether the proportion of each genotype 
obtained was in agreement with expected values calculated from allele frequencies. MetS and 
control groups were compared using the Student’s t-test for continuous variables and the χ2 test 
for categorical variables. Logistic regression analysis was used for calculating interaction of 
VEGF genetic variants with the trace elements intake in association with metabolic syndrome. In 
fact a very different issue from confounding is whether the presence or absence of a variable 
changes the effect of exposure on disease that called effect modification (Fletcher et al. 2013). In 
this analysis the effects of modification or the interaction term (SNPs × trace element) variable 
was calculated for each trace element and VEGF SNPs and then regression β for the risk of their 
interaction and metabolic syndrome was obtained. (Fletcher et al. 2013). Sex, age, smoking 
status and serum hs-CRP were adjusted (Askari et al. 2013). A p-value of 0.05 or less was 
considered as statistically significant and Statistical analysis was performed with SPSS 11.5 
software.  
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Results:   
The characteristics of subjects with and without MetS are shown in Table 1. Weight, Body Mass 
Index (BMI), hip and waist circumference, systolic and diastolic blood pressure and Triglyceride 
were significantly higher in metabolic syndrome subjects (P<0.001). Comparing MetS subjects 
with those without MetS, there were no significant differences in age, smoking statue and serum 
LDL- c. Serum levels of hs-CRP were significantly higher in MetS than in non-MetS subjects 
(Table 1). Dietary intakes of subjects are presented in table 2. There were no significant 
differences for trace elements intake apart from total dietary energy, between MetS and non-
MetS subjects. The characteristics of the genotyped  
The SNPs data are shown in Table 3. All SNPs in both populations were consistent with the 
Hardy-Weinberg equilibrium.  Effect modification or interaction between VEGF SNPs and trace 
elements intake are presented in table 4. After adjustment for age, gender, smoking statue and 
serum hs-CRP,  the CT and CC genotype of rs4416670 were significantly associated with the 
presence of MetS when considering dietary iron intake and the iron – SNPs interaction term in 
the analysis (β=1.48, P<0.05, β=2.46, P<0.05) respectively. This association was also seen for 
CT genotype along with copper, zinc, manganese and iodine variable in the risk of MetS 
(p<0.05) while there was no significant association between iron intake and rs4416670 SNP. In 
Table 5 interaction between zinc, manganese intake and rs6921438  
SNPs had a significant negative effect on the risk of MetS (β=-0.16, P=0.02, β=-0.31, P=0.02 
respectively). As shown in table 6, the interaction between iron intake and rs6993770 SNPs also 
had a significant positive effect on the risk of MetS (β=0.10, P= 0.04) but there was no 
interaction between trace elements intake and rs10738760 SNPs on the risk of MetS as shown in 
table 7.   
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Discussion:   
Nutrigenetics has emerged as a multidisciplinary field focusing on studying the interactions 
between nutritional and genetic factors and health outcomes (Perez-Martinez et al. 2008, 
Ordovas et al. 2004). Recent advances in nutrigenetics and nutrigenomics, two fields with 
distinct approaches to elucidate the interaction between diet and genes but with a common 
ultimate goal to optimize health through the personalization of diet, are providing powerful 
approaches to unravel the complex relationship between nutritional contents, genetic single 
nucleotide polymorphisMetS (SNPs), and the biological system as a whole (Perez-Martinez et al. 
2012).   
In this study for the first time we have shown the interactions between 4 SNPs of the VEGF gene 
that were independently associated with serum VEGF levels (rs6921438 and rs4416670 on 
chromosome 6p21.1, rs6993770 on chromosome 8q23.1, and rs10738760 on chromosome 
9p24.2) (Debette et al. 2011), and the intake of trace elements in association with the risk of 
MetS. Dietary iron intake interacted with the presence of the rs6993770 SNPs in determining the 
risk of MetS. Iron deficiency appeared to interact with the rs6993770 SNP (that regulates serum 
level of VEGF), in the risk of MetS. Furthermore, the CT and CC genotypes of the rs4416670 
SNP along with low intake of iron, copper, zinc, manganese and iodine was associated with the 
risk of MetS in comparison with TT genotype. Iron deficiency has been shown to be an 
additional important factor in enhancing VEGF concentrations in premenopausal women which 
can also result in hypoxic conditions in cancer tissue due to low hemoglobin concentrations in 
red blood cells (Jian et al. 2014, Xi et al. 2008). An association between low hemoglobin 
concentrations and increased serum VEGF concentrations also has also been reported in patients 
with cancer (Dunst et al.1999), so iron deficiency and low hemoglobin concentrations had the 
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significant relationship with serum VEGF. As stated previously, angiogenesis that activated by 
VEGF involves in construction new capillaries from main blood vessels which is a pivotal 
mechanism for shipping essential nutrients such as iron to the cells.  
We also showed a negative effect of the interaction between low detary zinc intake, high 
manganese intake and the rs6921438 SNPs in association with the risk of MetS. Bredow et al 
(2005), indicated in contrast with our finding that in nonpulmonary cell lines, manganese (Mn) 
induces cellular expression of VEGF in vitro. These data suggest that Mn might promote changes 
in pulmonary angiogenic growth factor expression, which, over time, could affect lung 
vasculature morphology, leading to enhanced susceptibility to diseases but in our study there was 
a negative interaction between Mn and VEGF regulatory SNPs. It was shown that intracellular 
zinc deprivation resulted in increased VEGF production by prostate cancer cells (Golovine et al. 
2008). Our results suggest that deficiency of some dietary factors may result in increased serum 
VEGF and more angiogenesis, affecting the transportation of essential nutrients to the body cells 
(Choi et al. 2011).  
Understanding the biological impact of gene-environment for example, nutrients, interactions 
will provide a key insight into the pathogenesis and progression of diet-related polygenic 
disorders. These studies indicate that therapeutic dietary therapy may require a 'personalized 
nutrition' approach, wherein a particular genetic profile may determine responsiveness of patients 
to specific dietary nutrient interventions. Not measuring serum  levels of VEGF  and trace 
elements may be  one important  limitation of our study. In order to understand the role of 
elements in the their interaction with VEGF SNPs we need further examinations with wider 
populations.  
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Conclusions:   
This study shown that in association with metabolic syndrome low iron intake had a positive 
interaction with rs6993770 SNPs while low zinc and high manganese intake had a negative 
interaction with rs6921438 SNPs. Finally, the described procedure of determination of elemental 
intake and their interaction with angiogenesis factors in this study could become a 
complementary diagnostic and therapeutic tool in medicine field.  
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Table 
   
Table 1: Baseline Characteristics of study population  
 Variable  Controls (n=100)  Metabolic Syndrome (n=248)  
Age (year)  50.92±8.01  51.33±7.34  
     
 
Current smoker  16(16.0%)  47(18.95%)  
Ex- smoker  10(10.0%)  19(7.66%)  
Never smoker  74(74.0%)  182(73.38%)  
LDL-C (mg/dl)  117.01±31.99  118.57±38.60  
hs-CRP (mg/L)  1.47(1.03-3.45)  2.13(1.35-3.96)**  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Data presented as mean ± SD for normal variables and median for abnormal variables  
*p<0.05, **p<0.01, ***p<0.001, compared to Controls  
Abbreviations: BMI: Body Mass Index, SBP: Systolic blood pressure, DBP: diastolic blood pressure, FBG: 
Fasting Blood Glucose,  TC: Total Cholesterol, hs-CRP: High sensitivity C-reactive protein,  LDL-C: Low density 
lipoprotein Cholesterol , HDL: high density lipoprotein Cholesterol,   
 
  
  
  
  
Gender n (%)  
Male  
 
47(47.0%)  
 
58(23.38%) ***  
Female  53(53.0%)  190(76.61%) ***  
Smoking       
Weight (kg)  70.65±12.22  76.51±12.21***  
BMI (kg/m2)  27.24±4.36  30.61±4.21***  
Hip circumference(cm)  102.55±8.92  106.83±9.22***  
Waist circumference (cm)  93.62±11.71  100.95±9.86***  
SBP (mmHg)  120.99±16.74  130.78±20.19***  
DBP (mmHg)  78.33±9.70  84.37±12.71***  
FBG (mg/dl)  91.17±43.97  92.65±31.24  
TC (mg/dl)  190.79±37.92  197.60±42.23  
HDL-C (mg/dl)  45.77±10.70  38.70±6.83***  
Triglyceride (mg/dl)  110(72-135)  173(136-230.5) ***  
Metabolic syndrome components  
2  
  
  
 
 
 
Table 2:  Nutritional intake of study population    
Variable  Controls (n=100)  Metabolic 
Syndrome(n=248)  
Energy (Kcal/day)  1660.91±623.05  1830.04±665.89*  
Iron (mg/ day)  10.95±6.16  10.14±3.95  
Copper (mg/day)  0.69±1.61  0.60±1.44  
Zink (mg/day)  7.29±3.35  7.02±2.46  
Manganese 
(mg/day)  
4.01±1.76  3.77±1.21  
Selenium (mg/day)  29.65±17.79  34.20±25.16  
Iodine (µg/day)  112.93±87.48  96.97±74.59  
Data were mean ± SD  
*p<0.05, **p<0.01, ***p<0.001, compared to Controls  
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Table 3. Characteristics of the four studied genetic variants  
  
 
            
SNP  Minor  Direction ofplasma VEGFA effect on a  Variance VEGFA explained 
(%) of  plasma   function allele  
 
6  rs6921438  A  -0.72  41.2  Intergenic  
6  rs4416670  C  -0.13  1.5  Intergenic  
8  rs6993770  T  -0.17  2.0  Intronic  
9  rs10738760  G  -0.28  5.0  Intergenic  
  
a according to the effect size in the discovery cohort (VEGFA values in ng/1, log -transformed)  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4  
  
 
 
 
 
  
Table 4: Interaction between trace elements intake and VEGF SNPs  
  
    Model 1  Model 2*  
Variable  Genotype  β  P  β  P  
rs4416670  TT  Normal  -      
CT  0.37  0.21  0.45  0.14  
CC  0.31  0.35  0.32  0.349  
rsA*Iron  TT  -  -  -  -  
CT  1.48  0.01  1.28  0.003  
CC  2.46  0.03  1.63  0.01  
rsA*Iron  -0.10  0.05  -0.05  0.03  
rsA*Copper  TT  -  -  -  -  
CT  0.58  0.06  0.69  0.03  
CC  0.48  0.19  0.49  0.19  
rsA*Copper  0.03  0.76  0.02  0.84  
rsA*Zinc  TT  -  -  -  -  
CT  0.90  0.03  0.97  0.02  
CC  1.00  0.13  0.97  0.15  
rsA*Zinc  -0.03  0.43  -0.02  0.47  
rsA*Manganese   TT  -  -  -  -  
CT  0.98  0.01  1.10  0.01  
CC  1.23  0.05  1.31  0.05  
rsA*Manganese  -0.08  0.21  -0.09  0.19  
rsA*Selenium   TT  -  -  -  -  
CT  0.44  0.22  0.53  0.16  
CC  0.14  0.76  0.12  0.80  
rsA*Selenium  0.007  0.25  0.007  0.23  
rsA*Iodine  TT  -  -  -  -  
CT  0.75  0.03  0.86  0.01  
CC  0.71  0.10  0.74  0.10  
rsA*Iodine  0.00  0.56  0.00  0.50  
  
Predictors in model1 analysis were rs4416670, iron, copper, zinc, selenium, Manganese and Iodine  
*  
Adjusted for age, gender, smoking and hs-CRP  
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Table 5: Interaction between trace elements intake and VEGF SNPs  
    Model 1  Model 2*  
Variable  Genotype  β  P  β  P  
rs6921438  GG  Normal  -  -  -  
AG  -0.28  0.42  -0.23  0.53  
AA  -0.21  0.56  -0.16  0.66  
rsB *Iron  GG  -  -  -  -  
AG  0.21  0.71  0.21  0.72  
AA  0.86  0.36  0.81  0.41  
rsB*Iron  -0.03  0.32  -0.03  0.41  
rsB *Copper  GG  -  -  -  -  
AG  -0.05  0.88  -0.02  0.95  
AA  0.28  0.53  0.31  0.52  
rsB *Copper  -0.27  0.16  -0.26  0.22  
rsB *Zinc  GG  -  -  -  -  
AG  0.98  0.09  0.98  0.10  
AA  2.46  0.01  2.40  0.03  
rsB  *Zinc  -0.17  0.01  -0.16  0.02  
rsB *Manganese   GG  -  -  -  -  
AG  0.95  0.13  1.02  0.12  
AA  2.46  0.04  2.57  0.03  
rsB *Manganese  -0.30  0.03  -0.31  0.03  
rsB *Selenium   GG  -  -  -  -  
AG  0.21  0.65  0.22  0.64  
AA  0.73  0.31  0.66  0.34  
rsB *Selenium  -0.01  0.26  -0.009  0.35  
rsB*Iodin  GG  -  -  -  -  
AG  -0.08  0.85  -0.13  0.78  
AA  0.14  1.15  -0.03  0.96  
rsB *Iodin  0.00  0.81  0.00  0.81  
  
Predictors in model1 analysis were rs6921438, iron, copper, zinc, selenium, Manganese and Iodine  
*  
Adjusted for age, gender, smoking and hs-CRP  
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Table 6: Interaction between trace elements intake and VEGF SNPs  
    Model 1  Model 2*  
Variable  Genotype  β  P  β  P  
rs6993770  AA  Normal  -  -  -  
AT  0.18  0.47  0.29  0.27  
TT  0.08  0.83  0.09  0.82  
rsC *Iron  AA  -  -  -  -  
AT  -1.02  0.10  -0.85  0.17  
TT  -2.03  0.06  -1.94  0.08  
rsA*Iron  0.10  0.04  0.10  0.04  
rsC *Copper  AA  -  -  -  -  
AT  0.12  0.70  0.20  0.53  
TT  0.10  0.84  0.06  0.90  
rsA*Copper  -0.001  0.99  0.05  0.80  
rsC *Zinc  AA  -  -  -  -  
AT  0.21  0.74  0.38  0.56  
TT  0.29  0.81  0.36  0.77  
rsA*Zinc  -0.01  0.83  -0.04  0.51  
rsC *Manganese   AA  -  -  -  -  
AT  0.02  0.97  0.31  0.65  
TT  -0.07  0.95  0.29  0.82  
rsA*Manganese  0.01  0.91  -0.02  0.89  
rsC *Selenium   AA  -  -  -  -  
AT  -0.49  0.30  -0.38  0.43  
TT  -1.02  0.22  -1.05  0.22  
rsA*Selenium  0.01  0.15  0.01  0.12  
rsC*Iodine  AA  -  -  -  -  
AT  0.25  0.54  0.47  0.27  
TT  0.44  0.57  0.59  0.45  
rsA*Iodine  -0.001  0.50  -0.002  0.40  
Predictors in model1 analysis were rs6993770, iron, copper, zinc, selenium, Manganese and Iodine  
*  
Adjusted for age, gender, smoking and hs-CRP  
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Table 7: Interaction between trace elements intake and VEGF SNPs  
  
  
    Model 1  Model 2*  
Variable  Genotype  β  P  β  P  
rs10738760  AA  Normal  -  -  -  
AG  0.32  0.22  0.32  0.23  
GG  0.21  0.52  0.21  0.52  
rsD *Iron  AA  -  -  -  -  
AG  0.04  0.70  0.03  0.94  
GG  0.06  0.94  -0.001  0.99  
rsD *Iron  0.01  0.77  0.01  0.67  
rsD *Copper  AA  -  -  -  -  
AG  0.40  0.22  0.43  0.21  
GG  0.71  0.13  0.74  0.13  
rsD *Copper  -0.29  0.18  -0.28  0.23  
rsD *Zinc  AA  -  -  -  -  
AG  -0.58  0.36  -0.47  0.47  
GG  -1.00  0.37  -0.85  0.46  
rsD *Zinc  0.09  0.19  0.08  0.25  
rsD *Manganese   AA  -  -  -  -  
AG  -0.11  0.87  0.10  0.88  
GG  -0.21  0.87  0.17  0.90  
rsD *Manganese  0.08  0.59  0.04  0.80  
rsD *Selenium   AA  -  -  -  -  
AG  0.31  0.48  0.40  0.39  
GG  0.71  0.35  0.85  0.29  
rsD *Selenium  -0.004  0.65  -0.006  0.56  
rsD*Iodine  AA  -  -  -  -  
AG  -0.03  0.94  0.10  0.82  
GG  0.001  0.99  0.16  0.81  
rsD *Iodine  0.001  0.50  0.00  0.75  
  
Predictors in model1 analysis were rs10738760, iron, copper, zinc, selenium, Manganese and Iodine  
*  
Adjusted for age, gender, smoking and hs-CRP  
  
 
  
